Application of a Neisseria meningitidis antigen microarray to identify candidate vaccine proteins from a human Phase I clinical trial (2022)
Attributed to:
UoOxford Confidence in Concept 2013
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.vaccine.2022.05.032
Publication URI: http://dx.doi.org/10.1016/j.vaccine.2022.05.032
Type: Journal Article/Review
Parent Publication: Vaccine
Issue: 28